MedTrace Logo

A Singapore Pilot Study to Assess Neurovision in Treatment of Low Myopia

NCT00348127 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2010-06-24

No results posted yet for this study

Summary

To assess how well and safe is Neurovision technology in improving the vision of people with low myopia in Singapore

Conditions

  • Myopia

Interventions

DEVICE

Neurovision

Sponsors & Collaborators

  • Singapore Eye Research Institute

    collaborator OTHER

  • NeuroVision

    collaborator INDUSTRY

  • Singapore National Eye Centre

    lead OTHER_GOV

Principal Investigators

  • Donald Tan, FRCS · Singapore Eye Research Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2004-10-31
Completion
2004-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348127 on ClinicalTrials.gov